Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
The Department of Transportation announced a new $1 billion grant program for airports. Grants are intended for family- and health-friendly improvements in airport terminals. Suggested upgrades ...
Boron, a chemical element next to carbon in the periodic table, is known for its unique ability to form complex bond networks. Unlike carbon, which typically bonds with two or three neighboring atoms, ...
TIOBE Index for December 2025: Top 10 Most Popular Programming Languages Your email has been sent December’s TIOBE Index lands with a quieter top tier but a livelier shuffle just beneath it. The main ...
If you think the economy is boring you've been listening to the wrong show. In our weekly podcast The Dip, we'll help you to connect the dots. Find DW's The Dip wherever you get your podcasts. Every ...
A Tesseract Ventures representative walks farmers through the program’s unique field data visualization features during a Innovation Connector event at Landus Cooperative headquarters in Des Moines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback